IDPH--Positive preliminary results for pivotal trial of ID

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
IDPH--Positive preliminary results for pivotal trial of ID

An SI Board Since June 1996

Posts	SubjectMarks	Bans	Symbol
1762	27	0	IDPH

Emcee: Roudy	Type: Unmoderated

Introduction Market Data Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
1487	Genetech sold a portion of their position. You can view the filing here freeed	Roudy	-	2/17/1998
1486	I heard rumors that Genetech has sold out there position in IDPH. Has anybod	guido leone	-	2/16/1998
1485	The California state social services program (welfare program) is called Medi-C	Roger Cranwill	-	2/12/1998
1484	Hi Contrarian, I can give you a view on the P&F chart analysis. The chart	Roudy	-	2/12/1998
1483	Hi Roger, Can you describe what a "formulary item" means. This seem	contrarian	-	2/12/1998
1482	For the record, Rituxan became a formulary item in the California Medi-Cal form	Roger Cranwill	-	2/12/1998
1481	Contrarian, Swarz's estimate changes are mentioned as "little noticed	Pseudo Biologist	-	2/6/1998
1480	Does the analyst state why he lowering estimates? Was there a conference call	contrarian	-	2/6/1998
1479	Jeff Swarz at Credit Suisse First Boston.	Kushi Kullar	-	2/6/1998
1478	Can you tell which brokerage firm it is ? Thanks. Don	Don Cheng	-	2/6/1998
1477	There was mention in Street.com re. a key analyst reducing earnings forecasts	Kushi Kullar	-	2/6/1998
1476	Thanks Greg for providing the information on the trials. I'll digest it.	Maurice Winn	-	2/6/1998
1475	Greg recommends 3 cycles of CHOP and radiotherapy for a stage I diffuse large c	DMB	1	2/5/1998
1474	SWOG Three Cycles of CHOP plus radiotherapy (RT is Superior to eight Cycles of	Gregory Rasp	-	2/5/1998
1473	Here is the ECOG trial published 3/1995 in abstract form. An ECOG Randomized P	Gregory Rasp	-	2/5/1998
1472	Here are the Q497 Earnings. IDEC made profit because of a milestone payment of	contrarian	-	2/5/1998
1471	Yttrium 90 does look much more promising than Rituxan according to the recent M	Gregory Rasp	-	2/4/1998
1470	I am very familiar with the trial. Actually there are two randomized trials th	Gregory Rasp	-	2/4/1998
1469	Greg, You said: "Lastly, I agree that in a 2cm node the use of Radiation	Maurice Winn	-	2/4/1998
1468	Thanks Greg for your comments. We are going to do some real life market resear	Maurice Winn	-	2/3/1998
1467	Don, Genentech already let the cat out of the bag on 4-th quarter Rituxan sales	Pseudo Biologist	-	2/2/1998
1466	If I remember correctly, I believe IDEC had Rituxan manufactured and available	Roudy	-	2/2/1998
1465	Whoa, fellas, I hope you're not expecting good earnings in IDEC's 4th q	Roger Cranwill	-	2/2/1998
1464	Don, Thanks for the informative post. What are your thoughts on potential pro	contrarian	-	1/31/1998
1463	Don: This again demonstrates that IDPH stock is a long-term investment. To pl	Don Cheng	-	1/29/1998

Go to reply# or date (mm/dd/yy):